phosphatidylcholines has been researched along with Black Fever in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, N; Banerjee, A; De, M | 1 |
| Ali, N; Roychoudhury, J; Sinha, R | 1 |
| Ali, N; Maji, M; Mazumder, S | 1 |
| Cos, P; Fortin, A; Hendrickx, S; Jansen, H; Maes, L; Yardley, V | 1 |
| del Castillo, A; Martínez, S; Piñero, JE; Portús, M; Valladares, B | 1 |
| Garnier, JM; Horelt, A; Minodier, P; Retornaz, K | 1 |
| Altieri, S; Coppola, MG; Faella, F; Gradoni, L; Gramiccia, M; Pagliano, P; Rescigno, C; Rossi, M; Scalone, A | 1 |
| Alvar, J; Clotet, B; Jiménez-Mejías, ME; Laguna, F; López-Vélez, R; Prados, D; Ribera, E; Sirera, G; Sust, M; Torre-Cisneros, J; Videla, S | 1 |
| Gradoni, L; Gramiccia, M; Scalone, A | 1 |
| Mehta, H; Murray, HW; Rai, M; Singh, SP; Sundar, S; Suresh, AV | 1 |
| Alvar, J; Arribas, JR; Boix, V; Cañavate, C; Górgolas, M; Jiménez-Mejías, ME; Laguna, F; López-Vélez, R; Márquez, M; Salas, A; Sust, M; Videla, S | 1 |
| Bongrand, MC; Chochoi, N; Faraut, F; Gallais, H; Gensollen, S; Monges, P; Montana, M; Ravaux, I; Timon-David, P | 1 |
| Ali, N; Pal, S; Ravindran, R | 1 |
| Goldsmith, DR; Perry, CM | 1 |
| Aguado, JM; González-Vidal, D; Lumbreras, C | 1 |
| Murray, HW | 1 |
| Ali, N; Bhowmick, S; Ravindran, R | 1 |
| Chance, ML; Heath, S; New, RR | 1 |
| Gam, AA; Kenney, RT; Murray, HW; Sacks, DL; Sundar, S | 1 |
| Goyal, AK; More, DK; Murray, HW; Singh, MK; Sundar, S | 1 |
| Croft, SL; Yardley, V | 1 |
| Goyal, AK; Makharia, MK; Mandal, AK; Murray, HW; Singh, VP; Sundar, S | 1 |
4 review(s) available for phosphatidylcholines and Black Fever
| Article | Year |
|---|---|
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure | 2003 |
[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].
Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome | 2004 |
Amphotericin B lipid complex: in visceral leishmaniasis.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Drug Combinations; Half-Life; Humans; Leishmaniasis, Visceral; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic | 2004 |
6 trial(s) available for phosphatidylcholines and Black Fever
| Article | Year |
|---|---|
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Double-Blind Method; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects; Treatment Outcome | 2003 |
Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Deoxycholic Acid; Drug Combinations; Drug Costs; Female; Hospital Costs; Humans; India; Infant; Leishmaniasis, Visceral; Liposomes; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Phosphatidylcholines; Phosphatidylglycerols | 2004 |
Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Incidence; Infant; Kidney Diseases; Leishmaniasis, Visceral; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.
Topics: Adolescent; Adult; Amphotericin B; Analysis of Variance; Antimony; Antiprotozoal Agents; Child; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Female; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Single-Blind Method | 1998 |
Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Antimony; Chi-Square Distribution; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leishmaniasis, Visceral; Male; Phosphatidylcholines; Phosphatidylglycerols; Probability; Treatment Outcome | 1999 |
12 other study(ies) available for phosphatidylcholines and Black Fever
| Article | Year |
|---|---|
Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.
Topics: Amines; Animals; Anti-Bacterial Agents; Cells, Cultured; Cricetinae; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunity, Humoral; Immunologic Factors; Interleukin-10; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Paromomycin; Phosphatidylcholines; Transforming Growth Factor beta | 2011 |
Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
Topics: Amines; Animals; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Proliferation; Cytokines; Drug Resistance; Fluoresceins; Immunity, Humoral; Immunomodulation; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Mice; Mice, Inbred BALB C; Nitric Oxide; Phosphatidylcholines; Rhodamine 123; Spleen | 2011 |
Potentiating effects of MPL on DSPC bearing cationic liposomes promote recombinant GP63 vaccine efficacy: high immunogenicity and protection.
Topics: Adjuvants, Immunologic; Animals; Cord Factors; Cytokines; Disease Models, Animal; Female; Humans; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Lipid A; Liposomes; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Nitric Oxide; Phosphatidylcholines; Th1 Cells; Vaccination; Vaccines, Synthetic | 2011 |
Efficacy and tolerability of oleylphosphocholine (OlPC) in a laboratory model of visceral leishmaniasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Bone Marrow; Cricetinae; Disease Models, Animal; Female; Inhibitory Concentration 50; Leishmaniasis, Visceral; Liver; Mesocricetus; Parasite Load; Parasitic Sensitivity Tests; Phosphatidylcholines; Spleen | 2012 |
In vitro susceptibility of Leishmania infantum strains isolated from Spanish HIV-positive patients to Abelcet and Fungizone.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Drug Combinations; HIV Seropositivity; Humans; Leishmania infantum; Leishmaniasis, Visceral; Patients; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Chi-Square Distribution; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Mediterranean Region; Middle Aged; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2003 |
Visceral leishmaniasis treatment, Italy.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Drug Combinations; Drug Therapy; Humans; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2003 |
Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Chronic Disease; Drug Carriers; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Liver; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Spleen | 2004 |
gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; CD8-Positive T-Lymphocytes; Dose-Response Relationship, Immunologic; Immunoglobulin G; Interferon-gamma; Interleukin-4; Leishmania donovani; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Liposomes; Liver; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Spleen; T-Lymphocyte Subsets; Th1 Cells; Time Factors | 2008 |
Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes.
Topics: Amphotericin B; Animals; Antifungal Agents; Leishmaniasis, Visceral; Liposomes; Liver; Mice; Mice, Inbred Strains; Phosphatidylcholines | 1981 |
Splenic cytokine responses in Indian kala-azar before and after treatment.
Topics: Adolescent; Adult; Amphotericin B; Antimony Sodium Gluconate; Cytokines; Drug Combinations; Humans; Interferon-gamma; Interleukin-10; Interleukin-4; Leishmaniasis, Visceral; Phosphatidylcholines; Phosphatidylglycerols; Spleen | 1998 |
A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cricetinae; Dose-Response Relationship, Drug; Drug Combinations; Female; Leishmania donovani; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Macrophages; Mesocricetus; Mice; Mice, Inbred BALB C; Phosphatidylcholines; Phosphatidylglycerols | 2000 |